John Mafi (@jnmafi) header
John Mafi (@jnmafi) profile picture

General internist and associate professor @UCLA studying healthcare innovation, value, and aging. Opinions my own.

Los Angeles, CA
Joined January 2011
Photo by John Mafi (@jnmafi)Photo by John Mafi (@jnmafi)Photo by John Mafi (@jnmafi)Photo by John Mafi (@jnmafi)Photo by John Mafi (@jnmafi)Photo by John Mafi (@jnmafi)Photo by John Mafi (@jnmafi)Photo by John Mafi (@jnmafi)Photo by John Mafi (@jnmafi)Photo by John Mafi (@jnmafi)
We published one of the first randomized trials of ambient AI scribes, the fastest-growing generative AI application in healthcare. 238 docs. 72K encounters. 2 tools tested over 2 months. Modest time savings. Reduced burnout. Docs reported better patient engagement. No major safety signals, but occasional inaccuracies mean vigilance remains key. Longer, multi-center RCTs needed. ai.nejm.org/doi/full/10.1056…
3
20
67
9,312
Very few AI tools for older adults have been tested in rigorous trials. We want to shrink the path from promising tool to real-world evidence from years to months. Up to $200K ($300K for a trial). Questions: [email protected]
1
33
John Mafi retweeted
My friend the brilliant @kevin_volpp dropped dead He survived (read abt it: tinyurl.com/ypcpdzpz) But every year 300-400,000 in the US don't This week: our @nature article (+A.Schubert J.Ross @m_sendhil M.Lingman) applies AI to this medical mystery nature.com/articles/s41586-0…
33
116
36
602
491,716
John Mafi retweeted
New letter in @JAMANetworkOpen! A clinically-oriented one examining the setting where meds affecting cognition (e.g., antipsychotics) are prescribed from. We find they are disproportionately prescribed from acute or post-acute settings (i.e., emergency room, hospital, SNF). 1/3
1
1
2
326
John Mafi retweeted
Between 2013 and 2021, older adults with cognitive impairment had higher rates of potentially inappropriate CNS-active prescriptions, most lacking clinical indications. ja.ma/4qjARAl
1
8
1
34
4,831
The true cost of the reconciliation bill will be measured in lives—over 50,000 per year. It’s a predictable result when you cut off insurance to people who are old, poor and sick. @eric_t_roberts and I discuss in @MSNBC @NBCNews @HarvardHPM @PennLDI msnbc.com/opinion/msnbc-opin…
6
10
1,354
I wrote up an FAQ about the recent federal grant cuts. A few key points 🧵:
2
72
6
206
39,332
AHEAD OF PRINT | The first two years of the COVID-19 pandemic saw an exponential increase in using repurposed medications to treat infections. Michelle S. Rockwell of @virginia_tech and coauthors explore demographic trends driving the surge in prescriptions and spending on hydroxychloroquine and ivermectin for COVID-19 treatment. Read the full article here: healthaffairs.org/doi/10.137…
1
4
2
1,227
What NIH purports to do here is illegal. In annual appropriations bills for the past several years, Congress has specifically banned NIH from changing indirect costs: congress.gov/118/plaws/publ4…
Last year, $9B of the $35B that the National Institutes of Health (NIH) granted for research was used for administrative overhead, what is known as “indirect costs.” Today, NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%, above what many major foundations allow and much lower than the 60%+ that some institutions charge the government today. This change will save more than $4B a year effective immediately.
24
187
27
758
160,195
1/ ‼️ NEW in @JAMAInternalMed. In our latest, @michelleskeller and I introduce a new research framework for older adults: “Deprescribing Equity.” A brief 🧵 on why this framework is needed and our recommendations for how we can achieve this goal. jamanetwork.com/journals/jam…
3
14
1
42
5,981
1/ NEW 📝 in @JAMANetworkOpen. In our latest from the REACH-AF Study, we asked: Does the racial & ethnic diversity of your VA medical center impact prescribing of stroke-reducing 💊 for #AFib. Short answer: YES! A 🧵 on what we found. #Pharmacoequity jamanetwork.com/journals/jam…
2
20
1
61
5,729
Very pleased to host the #SGIM24 Special Symposium on “Medical Misinformation in the Era of Artificial Intelligence” with @UrmimalaSarkar @walidgellad @wee_christina @ProfHayward @SocietyGIM
1
3
23
1,045
Brought to you by the SGIM Research Committee. Please reply here for questions for our esteemed panelists in the next 30 minutes
2
112
At the request of my friend, the amazing @drfolamay, I'd like to discuss "Nuances in the Colorectal Cancer Guidelines" for #ColorectalCancerAwarenessMonth. Let's dive into some primary care focused Q&As that shed light on screening and prevention 👇#CRCawareness @UCLAGIHep @esrailian @ArpanPatelMD @JenKolbMD
1
7
14
1,674